Comments 4

اللقاحات مقابل الجراثيم

Feb 11, 2016 Jim O'Neill

لندن - إن انتشار فيروس زيكا، مثل الإيبولا قبله، قد سلط الضوء على الخطر الذي تشكله الأمراض المعدية على صحة بلدان بأكملها - وكذا أهمية اللقاحات لمكافحة الأوبئة التي تتحرك بسرعة. في الواقع، إن الجهود جارية بالفعل لإيجاد السبل لتحصين الناس ضد كلا الفيروسين.

لكن اللقاحات لها دور مهم أيضا في حمايتنا ضد تهديد فتاك وأكثر قابلية للتنبؤ: عدوى مقاومة العقاقير.

وعلى عكس الانتشار السريع والغير متوقع مثل تفشي وباء زيكا، فاٍن مقاومة مضادات الميكروبات تشبه حادث سيارة بطيئة الحركة والذي بدأ بالفعل. إن مسببات الأمراض المقاومة تؤدي إلى حوالي 700.00 حالة وفاة كل عام. فإذا فشلنا في اتخاذ الاحتياطات اللازمة، سيتم قتل نحو عشرة ملايين شخص سنويا بحلول عام 2050.

To continue reading, please log in or enter your email address.

To continue reading, please log in or register now. After entering your email, you'll have access to two free articles every month. For unlimited access to Project Syndicate, subscribe now.

Featured

How Not to Fight Income Inequality

Nov 14, 2018 Ricardo Hausmann
Trump’s Diminishing Power and Rising Rage

Nov 12, 2018 Jeffrey D. Sachs
Why Freedom of Assembly Still Matters

Nov 13, 2018 Jan-Werner Mueller
Are You Buying Oil from Saudi Arabia?

Nov 12, 2018 Peter Singer
A Concert of Indo-Pacific Democracies

Nov 12, 2018 Brahma Chellaney

new comment has been posted. new comments have been posted.

0 Comments on this paragraph, 4 in all 4 Comments on this article

Robbie Jena Feb 11, 2016

Superbug and CDC...the world is really big with over seven Billion people. Why can not others do serious research on bugs? and find good solutions...
A new reply to this comment has been posted.
Michael Public Feb 11, 2016

The problem with vaccines is they can weaken your general system. They can save you improbable things like Rika and deliver you into the arms of probable things like Guillane-Barre Syndrone, Yuppie Flu or Cancer. Count me out.
A new reply to this comment has been posted.
Peter Belmont Feb 11, 2016

The outrageous pricing behavior of the so-called big-pharma (and maybe also little-pharma) makes me wonder -- can I be alone? -- if the capitalist model is the right model for drug R&D&manufacture&sale.

A lot of the research for new drugs and vaccines is done at universities, funded (I suppose) largely by government. If this is so, how much more of the process could usefully be done by government? The problem of providing inexpensive drugs to poor people (and in poor countries) has been recognized and is opposed by big-pharma, including in the proposed TPP.

Similarly, "capitalism" or "free enterprise" left to itself has done nothing to fight Global Warming/Climate Change adn continues (as I see it) to stand in the way of speedy (or even of not-quite-timely) action.

So perhaps, as far as human health is concerned, we should be seeking another model to replace and supplant "free enterprise" with a m,ecnanism that shows better promise of successfully fighting new, resistant, and "orphan" diseases.

Of course, the present system encourages certain deaths -- from diseases today, from climate later -- which is one way, I suppose, to do something we should be doing, namely, reducing the size of the human population. Maybe complaint is, therefore, misplaced. --sad face--
A new reply to this comment has been posted.
Steve Hurst Feb 11, 2016

With regard to the need for new antibiotics - It will be an entire waste of time unless the abuse or misuse of antibiotics - not least by the agri sector - is curtailed. Exisiting misuse is the game is still in play and delivering new resistant pathogens
A new reply to this comment has been posted.

http://prosyn.org/zdtSOqO/ar;

اللقاحات مقابل الجراثيم

To continue reading, please log in or enter your email address.

Featured

How Not to Fight Income Inequality

Trump’s Diminishing Power and Rising Rage

Why Freedom of Assembly Still Matters

Are You Buying Oil from Saudi Arabia?

A Concert of Indo-Pacific Democracies

New Comment

Email this piece to a friend

Contact us

Vaccinating Against Superbugs

Trump’s Protectionist Quagmire

Disaster Capitalism Comes to Puerto Rico

Rethinking Animal Agriculture

How Can Countries Reduce Poverty Faster?

The Media’s #MeToo Problem

PS. Explain This: The Gendered Right to Mobility

Electrifying Africa’s Labor Market

Cookies and Privacy

Log in/Register